Supersonic Imagine: directors' dealings · France · AMF

About Supersonic Imagine

SuperSonic Imagine is a French medical technology company focused on ultrasound imaging. Founded in 2005 in Aix-en-Provence by Jacques Souquet, the company was built around a disruptive innovation: an ultrafast ultrasound platform capable of delivering real-time imaging with high definition and strong diagnostic precision. Its flagship technology, the Aixplorer® platform, was designed to improve non-invasive diagnosis and tissue characterization, with key use cases in radiology and in the assessment of breast, liver and prostate diseases, as well as broader general-imaging applications. From the outset, SuperSonic Imagine differentiated itself in a market dominated by large global ultrasound manufacturers by focusing on image speed, image quality and advanced quantitative features, especially ShearWave™ elastography, which became one of the company’s signature technologies. In April 2014, the company listed its shares on Euronext Paris, a move that increased its visibility and strengthened its profile among investors and commercial partners. The company subsequently expanded its industrial and international footprint, with commercial activity in more than 50 countries and more than 800 installed systems at the time of its IPO communication. Its strategy was centered on distributing cart-based ultrasound solutions to hospitals, imaging centers and specialists who rely on ultrasound as a first-line diagnostic or follow-up tool. SuperSonic Imagine’s market position has therefore been that of a technology-led niche specialist, combining a meaningful installed base, international reach and a differentiated product portfolio in medical ultrasound. On the stock-market side, SuperSonic Imagine transferred its listing to Euronext Growth Paris effective 30 December 2020, while keeping the same ISIN code, FR0010526814. The company said the move was intended to better match its listing venue to its size, market capitalization and free float, while reducing certain listing obligations and costs. The company remained identified as a medtech specialist in ultrasound imaging. A notable corporate event was Hologic’s 2019 announcement of a binding offer to acquire SuperSonic Imagine. Hologic, a US-based leader in women’s health and medical imaging, said the transaction would strengthen its breast-health portfolio through SuperSonic Imagine’s cart-based ultrasound technology. That interest highlights the strategic value of the company’s intellectual property and its reputation as an innovative French ultrasound specialist in a competitive medtech landscape.